Peripherally Inserted Central Catheters Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Peripherally Inserted Central Catheters used intravenous access for a prolonged period of time. These catheters are recommended for cancer treatments, liquid nutrition, and infection treatments. Major drivers attributing to the growth of the market during the forecasted period comprises of increasing product approvals, increasing prevalence of cancer, increasing research and development activities. Furthermore, development of solutions that reduce the risk of catheter associated infections along with adoption of expansion strategies such as M&A strategies from major manufacturers to expand their product portfolio is anticipated to assist the market growth.

Key features of the study:

• This report provides in-depth analysis of the Global Peripherally Inserted Central Catheters market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the Global Peripherally Inserted Central Catheters market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, AngioDynamics, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated, Argon Medical Devices, Inc., Boston Scientific Corporation, Cook Medical Inc., ICU Medical Inc., Medical Components, Inc., Access Vascular, Medtronic, Inc., and Navilyst Medical, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The Global Peripherally Inserted Central Catheters market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Peripherally Inserted Central Catheters market

Detailed Segmentation:

Global Peripherally Inserted Central Catheters Market, By Product Type:

• Single Lumen
• Double Lumen
• Multiple Lumen

Global Peripherally Inserted Central Catheters Market, By End User:

• Hospitals
• Ambulatory Surgical Centers
• Catheterization Laboratories

Global Peripherally Inserted Central Catheters Market, By Region:

• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region
• South Africa
• Central Africa
• North Africa

Company Profiles

• AngioDynamics, Inc. *
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Teleflex Incorporated
• Argon Medical Devices, Inc.
• Boston Scientific Corporation
• Cook Medical Inc.
• ICU Medical Inc.
• Medical Components, Inc.
• Access Vascular
• Medtronic, Inc.
• Navilyst Medical, Inc.
• “*” marked represents similar segmentation in other categories in the respective section.